Long-lasting Discussion: Adverse Effects of Intraoperative Blood Loss and Allogeneic Transfusion on Prognosis of Patients with Gastric Cancer

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2019 Jun 26

PMID 31235997

Citations 33

Authors

Koki Nakanishi

Mitsuro Kanda

Yasuhiro Kodera

Affiliations

Soon will be listed here.

Abstract

Gastrectomy with radical lymph node dissection is the most promising treatment avenue for patients with gastric cancer. However, this procedure sometimes induces excessive intraoperative blood loss and requires perioperative allogeneic blood transfusion. There are lasting discussions and controversies about whether intraoperative blood loss or perioperative blood transfusion has adverse effects on the prognosis in patients with gastric cancer. We reviewed laboratory and clinical evidence of these associations in patients with gastric cancer. A large amount of clinical evidence supports the correlation between excessive intraoperative blood loss and adverse effects on the prognosis. The laboratory evidence revealed three possible causes of such adverse effects: anti-tumor immunosuppression, unfavorable postoperative conditions, and peritoneal recurrence by spillage of cancer cells into the pelvis. Several systematic reviews and meta-analyses have suggested the adverse effects of perioperative blood transfusions on prognostic parameters such as all-cause mortality, recurrence, and postoperative complications. There are two possible causes of adverse effects of blood transfusions on the prognosis: Anti-tumor immunosuppression and patient-related confounding factors (., preoperative anemia). These factors are associated with a worse prognosis and higher requirement for perioperative blood transfusions. Surgeons should make efforts to minimize intraoperative blood loss and transfusions during gastric cancer surgery to improve patients' prognosis.

Citing Articles

Impact of perioperative blood transfusion on elderly gastric cancer patients.

Zhang M, Feng Q, Wang M J Gastrointest Oncol. 2024; 15(4):2024-2025.

PMID: 39279921 PMC: 11399879. DOI: 10.21037/jgo-24-416.

Updated systematic review and meta‑analysis for risk predictors of 30‑day unplanned readmission following gastric cancer surgery.

Li J, Hu X, Zhang S Oncol Lett. 2024; 28(4):496.

PMID: 39211302 PMC: 11358720. DOI: 10.3892/ol.2024.14629.

Perioperative Immunosuppressive Factors during Cancer Surgery: An Updated Review.

Bezu L, Akcal Oksuz D, Bell M, Buggy D, Diaz-Cambronero O, Enlund M Cancers (Basel). 2024; 16(13).

PMID: 39001366 PMC: 11240822. DOI: 10.3390/cancers16132304.

Systematic Review and Meta-Analysis on the Role of Perioperative Blood Transfusion in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma.

Kochergin M, Fahmy O, Esken L, Goetze T, Xylinas E, Stief C Bladder Cancer. 2024; 8(3):315-327.

PMID: 38993684 PMC: 11181769. DOI: 10.3233/BLC-201534.

Effects of surgical trauma and intraoperative blood loss on tumour progression.

Jin X, Han H, Liang Q Front Oncol. 2024; 14:1412367.

PMID: 38912060 PMC: 11190163. DOI: 10.3389/fonc.2024.1412367.

References

Nielsen H, Werther K, Mynster T, Brunner N . Soluble vascular endothelial growth factor in various blood transfusion components. Transfusion. 1999; 39(10):1078-83. DOI: 10.1046/j.1537-2995.1999.39101078.x. View

Dhar D, Kubota H, Tachibana M, Kotoh T, Tabara H, Watanabe R . Long-term survival of transmural advanced gastric carcinoma following curative resection: multivariate analysis of prognostic factors. World J Surg. 2000; 24(5):588-93; discussion 593-4. DOI: 10.1007/s002689910099. View

Dresner S, Lamb P, Shenfine J, Hayes N, Griffin S . Prognostic significance of peri-operative blood transfusion following radical resection for oesophageal carcinoma. Eur J Surg Oncol. 2000; 26(5):492-7. DOI: 10.1053/ejso.1999.0929. View

Sun C, Hsieh Y, Ngan K, Wang W . Search for immunomodulatory effects of blood transfusion in gastric cancer patients: flow cytometry of Th1/Th2 cells in peripheral blood. Ann Clin Lab Sci. 2001; 31(2):171-8. View

Christein J, Hollinger E, Millikan K . Prognostic factors associated with resectable carcinoma of the esophagus. Am Surg. 2002; 68(3):258-62; discussion 262-3. View

Ferrara N, Gerber H, LeCouter J . The biology of VEGF and its receptors. Nat Med. 2003; 9(6):669-76. DOI: 10.1038/nm0603-669. View

Roelen D, Brand A, Claas F . Pretransplant blood transfusions revisited: a role for CD(4+) regulatory T cells?. Transplantation. 2004; 77(1 Suppl):S26-8. DOI: 10.1097/01.TP.0000106469.12073.01. View

Beghe C, Wilson A, Ershler W . Prevalence and outcomes of anemia in geriatrics: a systematic review of the literature. Am J Med. 2004; 116 Suppl 7A:3S-10S. DOI: 10.1016/j.amjmed.2003.12.009. View

van Hilten J, van de Watering L, van Bockel J, van de Velde C, Kievit J, Brand R . Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery. BMJ. 2004; 328(7451):1281. PMC: 420164. DOI: 10.1136/bmj.38103.735266.55. View

10.

Miki C, Hiro J, Ojima E, Inoue Y, Mohri Y, Kusunoki M . Perioperative allogeneic blood transfusion, the related cytokine response and long-term survival after potentially curative resection of colorectal cancer. Clin Oncol (R Coll Radiol). 2006; 18(1):60-6. DOI: 10.1016/j.clon.2005.08.004. View

11.

Chen G, Zhang F, Gong M, Yan M . Effect of perioperative autologous versus allogeneic blood transfusion on the immune system in gastric cancer patients. J Zhejiang Univ Sci B. 2007; 8(8):560-5. PMC: 1934950. DOI: 10.1631/jzus.2007.B0560. View

12.

Baumgartner J, Silliman C, Moore E, Banerjee A, McCarter M . Stored red blood cell transfusion induces regulatory T cells. J Am Coll Surg. 2009; 208(1):110-9. PMC: 5787354. DOI: 10.1016/j.jamcollsurg.2008.08.012. View

13.

Kamei T, Kitayama J, Yamashita H, Nagawa H . Intraoperative blood loss is a critical risk factor for peritoneal recurrence after curative resection of advanced gastric cancer. World J Surg. 2009; 33(6):1240-6. DOI: 10.1007/s00268-009-9979-4. View

14.

Lange M, van Hilten J, van de Watering L, Bijnen B, Roumen R, Putter H . Leucocyte depletion of perioperative blood transfusion does not affect long-term survival and recurrence in patients with gastrointestinal cancer. Br J Surg. 2009; 96(7):734-40. DOI: 10.1002/bjs.6636. View

15.

Ojima T, Iwahashi M, Nakamori M, Nakamura M, Naka T, Katsuda M . Association of allogeneic blood transfusions and long-term survival of patients with gastric cancer after curative gastrectomy. J Gastrointest Surg. 2009; 13(10):1821-30. DOI: 10.1007/s11605-009-0973-9. View

16.

Sima C, Jarnagin W, Fong Y, Elkin E, Fischer M, Wuest D . Predicting the risk of perioperative transfusion for patients undergoing elective hepatectomy. Ann Surg. 2009; 250(6):914-21. DOI: 10.1097/sla.0b013e3181b7fad3. View

17.

Kanda M, Fujii T, Kodera Y, NAGAI S, Takeda S, Nakao A . Nutritional predictors of postoperative outcome in pancreatic cancer. Br J Surg. 2010; 98(2):268-74. DOI: 10.1002/bjs.7305. View

18.

Pacelli F, Rosa F, Marrelli D, Pedrazzani C, Bossola M, Zoccali M . Do perioperative blood transfusions influence prognosis of gastric cancer patients? Analysis of 927 patients and interactions with splenectomy. Ann Surg Oncol. 2011; 18(6):1615-23. DOI: 10.1245/s10434-010-1543-9. View

19.

Sasako M, Sakuramoto S, Katai H, Kinoshita T, Furukawa H, Yamaguchi T . Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol. 2011; 29(33):4387-93. DOI: 10.1200/JCO.2011.36.5908. View

20.

Shander A, Van Aken H, Colomina M, Gombotz H, Hofmann A, Krauspe R . Patient blood management in Europe. Br J Anaesth. 2012; 109(1):55-68. PMC: 3374574. DOI: 10.1093/bja/aes139. View